Ethical Issues in the Pharmaceutical Industry
VerifiedAdded on 2023/04/21
|11
|3495
|225
AI Summary
This essay discusses the ethical issues in the pharmaceutical industry, such as clinical pharmacy practice, pharmaceutical care, and more. It also explores the CSR policies pursued by pharmaceutical companies. The document type is an essay and the assignment type is a research paper. The subject is not mentioned, and there is no specific course code or college/university mentioned.
Contribute Materials
Your contribution can guide someone’s learning journey. Share your
documents today.
Running head: CORPORATE SOCIAL RESPONSIBILITY
Corporate Social Responsibility
Name of the Student
Name of the University
Author’s Note
Corporate Social Responsibility
Name of the Student
Name of the University
Author’s Note
Secure Best Marks with AI Grader
Need help grading? Try our AI Grader for instant feedback on your assignments.
1CORPORATE SOCIAL RESPONSIBILITY
Introduction
The present essay provides an insight on the core ethical issues in the
pharmaceutical industry. The pharmaceutical enterprise have crucial role for the
widespread recovery of effectiveness in the healthcare industry. The international
institutions intervened with the framework of ethical code that mainly represent
minimum standards the enterprise respect to attain good ethical practices. At present,
most of the pharmaceutical companies maintain ethics in its business operations.
Ethical values of pharmaceutics are directly related to professional responsibilities of the
pharmacists (Publications.parliament 2018). The major ethical values of pharmaceutics
involve- respect for the patient’s dignity, non-maleficence, beneficence, honesty,
empathy, cooperation. Over the years, as the role of pharmacists have changed
considerably, numerous ethical issues occurs relating to varied aspects of discipline.
The pharmacists being one of the health –care providers face ethical problems in form
of pharmaceutical care, cooperation with health- care team and relationship with the
patients. In few nations, especially in US and UK, the pharmacies are involved in
primary care service industry and few have special prescription rights. However, they
are faced with issues regarding requirement of technical skills and consideration of
ethical values. Due to such ethical issues, the pharmacists use code of ethics for
safeguarding their profession The National Board of Registration of Pharmacists provide
the code of conduct for assuring highest level of ethical as well as moral practice by the
pharmacists (Schenker, Arnold and London 2014). In fact, these bodies also monitor the
pharmacists for assuring that they meet standard of ethics and consumers attain
highest quality medicine products with safety. The code of ethics takes into account
values of CSR (corporate Social Responsibility) and protection of the stakeholder’s
interest with whom the enterprise interacts. The CSR policies that the companies in
pharmaceutical sector have pursued are critically assessed in this study.
Discussion
Ethical issues in the pharmaceutical industry
Clinical pharmacy practice
Introduction
The present essay provides an insight on the core ethical issues in the
pharmaceutical industry. The pharmaceutical enterprise have crucial role for the
widespread recovery of effectiveness in the healthcare industry. The international
institutions intervened with the framework of ethical code that mainly represent
minimum standards the enterprise respect to attain good ethical practices. At present,
most of the pharmaceutical companies maintain ethics in its business operations.
Ethical values of pharmaceutics are directly related to professional responsibilities of the
pharmacists (Publications.parliament 2018). The major ethical values of pharmaceutics
involve- respect for the patient’s dignity, non-maleficence, beneficence, honesty,
empathy, cooperation. Over the years, as the role of pharmacists have changed
considerably, numerous ethical issues occurs relating to varied aspects of discipline.
The pharmacists being one of the health –care providers face ethical problems in form
of pharmaceutical care, cooperation with health- care team and relationship with the
patients. In few nations, especially in US and UK, the pharmacies are involved in
primary care service industry and few have special prescription rights. However, they
are faced with issues regarding requirement of technical skills and consideration of
ethical values. Due to such ethical issues, the pharmacists use code of ethics for
safeguarding their profession The National Board of Registration of Pharmacists provide
the code of conduct for assuring highest level of ethical as well as moral practice by the
pharmacists (Schenker, Arnold and London 2014). In fact, these bodies also monitor the
pharmacists for assuring that they meet standard of ethics and consumers attain
highest quality medicine products with safety. The code of ethics takes into account
values of CSR (corporate Social Responsibility) and protection of the stakeholder’s
interest with whom the enterprise interacts. The CSR policies that the companies in
pharmaceutical sector have pursued are critically assessed in this study.
Discussion
Ethical issues in the pharmaceutical industry
Clinical pharmacy practice
2CORPORATE SOCIAL RESPONSIBILITY
Pharmaceutical care
Ethical issues might occur in regular clinical pharmacy practice. Pharmaceutical
care relates to pharmacists responsibility for the drug therapy to achieve best result that
promote patient’s quality of life. Few ethical issues that occur in pharmaceutical care
practice involve – patient’s privacy, confidentiality, duty to warn, autonomy,
competencies to decide about procurement of best medication. Lack of confidentiality
assurance might cause unwillingness to disclose data by the patient, which in turn
creates numerous obstacles to pharmaceutical care. Another crucial role played by
pharmacists is to select best medications for the patients. The pharmacists are required
to balance varied objectives that include- reduction of drug cost, cost utility of drugs,
cost – benefit and total cost of illness (Cdn.intechopen 2018). However, the decisive
position of pharmacists might lead to ethical questions relating to this sector. As a
result, problems might result from advertising activity and other medical relating
activities.
Ethical issue might also arise in certain situation when the pharmacists assists
physician in the therapy but has not been permitted to comment on the shortcomings of
professionals.
Dispensing of drugs
Another ethical issue might occur in professionally dispensing of medicine by the
pharmacists. This requires provision of proper information on drug dosage depending
on several factors, warnings, contraindications and few precautions. There are some
legal regulations that permit the pharmacists to refuse selling of medicine, which in turn
might put patient’s life at risk. Few countries especially UK permit the pharmacists to
decline dispensing of drug due to their individual belief (Allen and Ansel 2013). In these
circumstances, ethical values of pharmacists mainly remains in clash with patient
autonomy and dignity. Nevertheless, numerous cases occur such as- cyberdoctors
creating potential harms, selling drugs without any prescriptions (Cdn.intechopen 2018).
Prescribing of POM (Pharmacy only Medicines)
Pharmaceutical care
Ethical issues might occur in regular clinical pharmacy practice. Pharmaceutical
care relates to pharmacists responsibility for the drug therapy to achieve best result that
promote patient’s quality of life. Few ethical issues that occur in pharmaceutical care
practice involve – patient’s privacy, confidentiality, duty to warn, autonomy,
competencies to decide about procurement of best medication. Lack of confidentiality
assurance might cause unwillingness to disclose data by the patient, which in turn
creates numerous obstacles to pharmaceutical care. Another crucial role played by
pharmacists is to select best medications for the patients. The pharmacists are required
to balance varied objectives that include- reduction of drug cost, cost utility of drugs,
cost – benefit and total cost of illness (Cdn.intechopen 2018). However, the decisive
position of pharmacists might lead to ethical questions relating to this sector. As a
result, problems might result from advertising activity and other medical relating
activities.
Ethical issue might also arise in certain situation when the pharmacists assists
physician in the therapy but has not been permitted to comment on the shortcomings of
professionals.
Dispensing of drugs
Another ethical issue might occur in professionally dispensing of medicine by the
pharmacists. This requires provision of proper information on drug dosage depending
on several factors, warnings, contraindications and few precautions. There are some
legal regulations that permit the pharmacists to refuse selling of medicine, which in turn
might put patient’s life at risk. Few countries especially UK permit the pharmacists to
decline dispensing of drug due to their individual belief (Allen and Ansel 2013). In these
circumstances, ethical values of pharmacists mainly remains in clash with patient
autonomy and dignity. Nevertheless, numerous cases occur such as- cyberdoctors
creating potential harms, selling drugs without any prescriptions (Cdn.intechopen 2018).
Prescribing of POM (Pharmacy only Medicines)
3CORPORATE SOCIAL RESPONSIBILITY
Based on the nation’s regulation, the pharmacists are permitted to sell drugs
without prescription from physician. This involves setting of proper regulations by the
authority for ensuring public safety. In this situation, pharmacists has to take decision
regarding selling of medicines to the youngsters. However, non- prescription of
medicine and self-medication creates ethical challenge to the pharmacists as improper
dosing might lead to death of patient (Braithwaite 2013). Thus, serious ethical issue lies
on the pharmacists decision of selling drugs without any prescription and proper
information about the drug.
Extemporaneous pharmaceutical preparations
Extemporaneous pharmaceutical preparations are basically unlicensed medicine.
Some of the country‘s regulation do not need these to be concerned with efficacy,
bioavailability, quality and safety (Publications.parliament 2018). However, ethical
problem occurs with assurance of drug quality in the extemporaneous preparations due
to no need for medicine registration. In this situation, the pharmacists face challenges in
preparing such medicines based on their basic knowledge and giving proper data for
avoiding unintended harms. Nevertheless, stability issues can occur from
extemporaneous preparations, which may involve- loss of uniformity, variation of
bioavailability, degradation of drugs causing toxicity (Darrow et al. 2015).
Ethical issues in production of pharmaceutical commodities
The Pharmaceutical producers are not only producer of drugs as well as dosage
forms but also develop and produce medicine licensed for medical use. Since the
pharmacists are subjected to different rules and regulations with regard to production,
testing and assuring quality of drugs, ethical issues might occur due to improper nations
law (Light, Lexchin and Darrow 2013).
Assurance of quality in pharmaceutical manufacturing
Assurance of medicine quality include varied aspects such as- production,
control of quality, distribution and monitoring. However, ethical issues might occur while
producing quality medicine as it needs effectual management of the company. If the
management of the pharmaceutical organization does not integrate preventive
Based on the nation’s regulation, the pharmacists are permitted to sell drugs
without prescription from physician. This involves setting of proper regulations by the
authority for ensuring public safety. In this situation, pharmacists has to take decision
regarding selling of medicines to the youngsters. However, non- prescription of
medicine and self-medication creates ethical challenge to the pharmacists as improper
dosing might lead to death of patient (Braithwaite 2013). Thus, serious ethical issue lies
on the pharmacists decision of selling drugs without any prescription and proper
information about the drug.
Extemporaneous pharmaceutical preparations
Extemporaneous pharmaceutical preparations are basically unlicensed medicine.
Some of the country‘s regulation do not need these to be concerned with efficacy,
bioavailability, quality and safety (Publications.parliament 2018). However, ethical
problem occurs with assurance of drug quality in the extemporaneous preparations due
to no need for medicine registration. In this situation, the pharmacists face challenges in
preparing such medicines based on their basic knowledge and giving proper data for
avoiding unintended harms. Nevertheless, stability issues can occur from
extemporaneous preparations, which may involve- loss of uniformity, variation of
bioavailability, degradation of drugs causing toxicity (Darrow et al. 2015).
Ethical issues in production of pharmaceutical commodities
The Pharmaceutical producers are not only producer of drugs as well as dosage
forms but also develop and produce medicine licensed for medical use. Since the
pharmacists are subjected to different rules and regulations with regard to production,
testing and assuring quality of drugs, ethical issues might occur due to improper nations
law (Light, Lexchin and Darrow 2013).
Assurance of quality in pharmaceutical manufacturing
Assurance of medicine quality include varied aspects such as- production,
control of quality, distribution and monitoring. However, ethical issues might occur while
producing quality medicine as it needs effectual management of the company. If the
management of the pharmaceutical organization does not integrate preventive
Secure Best Marks with AI Grader
Need help grading? Try our AI Grader for instant feedback on your assignments.
4CORPORATE SOCIAL RESPONSIBILITY
measures then it might adversely impact on the drug quality. Thus, quality assurance of
drugs requires high ethical conduct from the pharmacists for integrating quality into the
pharmaceutical commodities.
Proper medicine storage and distribution practice
The quality of medicine might be influenced by lack of proper control over several
activities that arise during storage as well as distribution practice. Proper guidelines to
storage as well as distribution of drugs helps to ensure quality of such pharmaceutical
products. For maintaining quality and safety, each activity in storage as well as
distribution of drugs is carried out based on principles of GSP, GDP and GMP. As
storage as well as distribution of drugs are different in different nations, ethical issues
occur for the pharmacists operating in that nation. Another ethical issue in GDP and
GSP is cold chain system in handling of pharmaceuticals that need vaccines. Moreover,
disruption of cold chain might result in non- effectiveness of vaccination. Nevertheless,
there might be breach of ethics if the pharmacy product is reinstalled with new tag when
cold chain system disrupts.
Ethical issues occurring on import and export of medicine
Import and export relates to the actions on drug distribution that are mainly
controlled by licenses. The pharmacists having such licenses are required to have high
ethics level as medicines are often diverted to illegal channels. The pharmacists having
less ethics might create issues because dangerous drugs might lead to death of
patients or their stake can be at stake.
Professional code of ethics for the pharmacists
There are few code of ethics for the pharmacists that include- respect for the
patients dignity, empathy, honesty, beneficence, cooperation and so on. Proper ethical
relation between patients, pharmacists and physicians is necessary as it helps them to
meet their own needs. These code of ethics are explained below-
Respect for the patients dignity
measures then it might adversely impact on the drug quality. Thus, quality assurance of
drugs requires high ethical conduct from the pharmacists for integrating quality into the
pharmaceutical commodities.
Proper medicine storage and distribution practice
The quality of medicine might be influenced by lack of proper control over several
activities that arise during storage as well as distribution practice. Proper guidelines to
storage as well as distribution of drugs helps to ensure quality of such pharmaceutical
products. For maintaining quality and safety, each activity in storage as well as
distribution of drugs is carried out based on principles of GSP, GDP and GMP. As
storage as well as distribution of drugs are different in different nations, ethical issues
occur for the pharmacists operating in that nation. Another ethical issue in GDP and
GSP is cold chain system in handling of pharmaceuticals that need vaccines. Moreover,
disruption of cold chain might result in non- effectiveness of vaccination. Nevertheless,
there might be breach of ethics if the pharmacy product is reinstalled with new tag when
cold chain system disrupts.
Ethical issues occurring on import and export of medicine
Import and export relates to the actions on drug distribution that are mainly
controlled by licenses. The pharmacists having such licenses are required to have high
ethics level as medicines are often diverted to illegal channels. The pharmacists having
less ethics might create issues because dangerous drugs might lead to death of
patients or their stake can be at stake.
Professional code of ethics for the pharmacists
There are few code of ethics for the pharmacists that include- respect for the
patients dignity, empathy, honesty, beneficence, cooperation and so on. Proper ethical
relation between patients, pharmacists and physicians is necessary as it helps them to
meet their own needs. These code of ethics are explained below-
Respect for the patients dignity
5CORPORATE SOCIAL RESPONSIBILITY
Patients require detail information regarding their medications and also prefer to
discuss health issues with their healthcare provider. However, it is the responsibility of
the pharmacists to fulfill information gap but could not due to lack of proper knowledge
(Salari et al. 2013). For instance, recent studies on UK has reflected that few
pharmacists provided proper drug information, which in turn lowers their treatment
costs. Therefore, pharmacists should build their relationship with the patients for
attracting their trust on the pharmacy system. As patient consultation has been the most
crucial ethical issue in pharmacy practice, the pharmacists should comply with this
ethical code of conduct.
Empathy
Showing empathy with the patients by cooperating with physicians is another
major concern of the pharmacists. The pharmacists can provide patient oriented service
according to the patients interest and thus build better relationship with them. Few
evidences in UK reflects that faults occurred from pharmacists that include dispensing
drugs, improper self- trafficking and improper self- medication might lead to loss of
confidence to the pharmacists.
Honesty
Honest pharmacists do not sell any kind of harmful pharmaceutical products that
provide adverse impact on the patients. There are some pharmacies in UK or other
nations that sell alcohol, cigarettes that are totally banned for the patients. This raises
ethical problems for the pharmacists if consumption of such products adversely affects
the health of patients.
Beneficence
Beneficence to patients has been provided at the target of optimizing drug
therapy as per interest of patients. One of the vital issues in this ethical code is
pharmacists responsibility of selling drug. Pharmacists are identified as eligible
healthcare experts to give advice to the patients on the heath products and more
information on drug. Their responsibility is to counsel customers about the benefits of
Patients require detail information regarding their medications and also prefer to
discuss health issues with their healthcare provider. However, it is the responsibility of
the pharmacists to fulfill information gap but could not due to lack of proper knowledge
(Salari et al. 2013). For instance, recent studies on UK has reflected that few
pharmacists provided proper drug information, which in turn lowers their treatment
costs. Therefore, pharmacists should build their relationship with the patients for
attracting their trust on the pharmacy system. As patient consultation has been the most
crucial ethical issue in pharmacy practice, the pharmacists should comply with this
ethical code of conduct.
Empathy
Showing empathy with the patients by cooperating with physicians is another
major concern of the pharmacists. The pharmacists can provide patient oriented service
according to the patients interest and thus build better relationship with them. Few
evidences in UK reflects that faults occurred from pharmacists that include dispensing
drugs, improper self- trafficking and improper self- medication might lead to loss of
confidence to the pharmacists.
Honesty
Honest pharmacists do not sell any kind of harmful pharmaceutical products that
provide adverse impact on the patients. There are some pharmacies in UK or other
nations that sell alcohol, cigarettes that are totally banned for the patients. This raises
ethical problems for the pharmacists if consumption of such products adversely affects
the health of patients.
Beneficence
Beneficence to patients has been provided at the target of optimizing drug
therapy as per interest of patients. One of the vital issues in this ethical code is
pharmacists responsibility of selling drug. Pharmacists are identified as eligible
healthcare experts to give advice to the patients on the heath products and more
information on drug. Their responsibility is to counsel customers about the benefits of
6CORPORATE SOCIAL RESPONSIBILITY
pharmacy products. If there is informed objection, then this ethical code indicates that
the pharmacists must redirect patient to other substitute sources.
Cooperation
The pharmacists are motivated to cooperate with other health- care providers in
order to provide better healthcare service to the patients. At present, the pharmacist in
most of the developed nations maintains this ethical code of conduct in order to avoid
any kind of risk regarding patient’s health (Youtie and Bozeman 2014).
CSR policies that companies in pharmaceutical industry pursues
In face of ethical issues, it is necessary for the pharmaceutical industry to
address these issues through strategic Corporate Social Responsibility (CSR) actions.
CSR relates to the commitment provided by the business to improve well- being of the
community through proper business practices as well as huge contribution of the
corporate resources (Salton and Jones 2015). It is the concept where the companies
adopt social as well as environmental concerns in the business operations and also in
interaction with its stakeholders. Now-a- days the pharmaceutical company integrate
CSR programs that mainly focus on health and well- being of people. These
pharmaceutical companies also give fund, equipment and medicines to the non- profit
enterprise that mainly work towards enhancing health of under- served communities
(Filatotchev and Stahl 2015). The CSR policy that the companies in the pharmaceutical
sector across the globe pursues are given below-
Serving the whole community of the respective nations. This means that every
company has the key priority to address the needs of the patients and give back
to community.
The Pharmaceutical company concentrate on quality support for meeting the
requirements of the society of respective countries (Turcsanyi and Sisaye 2013).
Leveraging Pharmaceutical companies resources that involves- marketing,
human resources, research and other products for maximizing effect on social
initiatives.
pharmacy products. If there is informed objection, then this ethical code indicates that
the pharmacists must redirect patient to other substitute sources.
Cooperation
The pharmacists are motivated to cooperate with other health- care providers in
order to provide better healthcare service to the patients. At present, the pharmacist in
most of the developed nations maintains this ethical code of conduct in order to avoid
any kind of risk regarding patient’s health (Youtie and Bozeman 2014).
CSR policies that companies in pharmaceutical industry pursues
In face of ethical issues, it is necessary for the pharmaceutical industry to
address these issues through strategic Corporate Social Responsibility (CSR) actions.
CSR relates to the commitment provided by the business to improve well- being of the
community through proper business practices as well as huge contribution of the
corporate resources (Salton and Jones 2015). It is the concept where the companies
adopt social as well as environmental concerns in the business operations and also in
interaction with its stakeholders. Now-a- days the pharmaceutical company integrate
CSR programs that mainly focus on health and well- being of people. These
pharmaceutical companies also give fund, equipment and medicines to the non- profit
enterprise that mainly work towards enhancing health of under- served communities
(Filatotchev and Stahl 2015). The CSR policy that the companies in the pharmaceutical
sector across the globe pursues are given below-
Serving the whole community of the respective nations. This means that every
company has the key priority to address the needs of the patients and give back
to community.
The Pharmaceutical company concentrate on quality support for meeting the
requirements of the society of respective countries (Turcsanyi and Sisaye 2013).
Leveraging Pharmaceutical companies resources that involves- marketing,
human resources, research and other products for maximizing effect on social
initiatives.
Paraphrase This Document
Need a fresh take? Get an instant paraphrase of this document with our AI Paraphraser
7CORPORATE SOCIAL RESPONSIBILITY
The companies under this pharmaceutical sector ensure sustainability by
introducing interventions in communities that address vital requirements and
become sustainable over the period of time (Salton and Jones 2015).
Overall, the CSR activities of the pharmaceutical companies include- education and
livelihood, preventive healthcare, water management, disaster relief and so on.
Examples of CSR policies adopted by the pharmaceutical companies operating in UK
Ethical issues in pharmaceutical industry is primarily based on the rules and
regulations followed by the company. The key ethical issues faced by the
pharmaceutical industry is the drug pricing issues faced by the company operating in
the United Kingdom. The consumers of the Pharmaceutical products in the United
Kingdom are significantly affected by the rise in the price of the Pharmaceutical product
as they play a significant role in the demand and supply functions of the products and
services provided. The rise in the price of the pharmaceutical product has not been in
proportionate basis for the industry (Mehralian et al. 2016). The policies followed by the
government in the regulation of the pharmaceutical industry is the rules and regulation
followed by the govermnet. Companies operating in the pharmaceutical industry needs
to act ethically and be transparent in the field of development and invention of new
products of the pharmaceutical industry. Patent laws and monopolistic pricing is some
of the key ethical issues faced by the pharmaceutical industry (Mehralian et al. 2016).
Pharmaceutical companies have to obtain and meet certain regulatory rules and
regulations and acquire patent rights for the products innovated and developed by the
company. In the United Kingdom the pharmaceutical industry is being regulated by the
MHRA body. The Regulatory body MHRA is an key executive agency for the
department of health. The MHRA or Medicine and HealthCare products regulatory
Agency is the key regulator in the United Kingdom which approves and guides all the
rules and the regulations in the United Kingdom (Darrow et al. 2015).
Pharmaceutical Industry in UK has shown key interest in there idea for
supporting the various type of Corporate Social Responsibility as the same helps the
company in involvement in various types of activities which are for the wellbeing of the
society in general along with the business of the companies (Das 2016). The CSR
The companies under this pharmaceutical sector ensure sustainability by
introducing interventions in communities that address vital requirements and
become sustainable over the period of time (Salton and Jones 2015).
Overall, the CSR activities of the pharmaceutical companies include- education and
livelihood, preventive healthcare, water management, disaster relief and so on.
Examples of CSR policies adopted by the pharmaceutical companies operating in UK
Ethical issues in pharmaceutical industry is primarily based on the rules and
regulations followed by the company. The key ethical issues faced by the
pharmaceutical industry is the drug pricing issues faced by the company operating in
the United Kingdom. The consumers of the Pharmaceutical products in the United
Kingdom are significantly affected by the rise in the price of the Pharmaceutical product
as they play a significant role in the demand and supply functions of the products and
services provided. The rise in the price of the pharmaceutical product has not been in
proportionate basis for the industry (Mehralian et al. 2016). The policies followed by the
government in the regulation of the pharmaceutical industry is the rules and regulation
followed by the govermnet. Companies operating in the pharmaceutical industry needs
to act ethically and be transparent in the field of development and invention of new
products of the pharmaceutical industry. Patent laws and monopolistic pricing is some
of the key ethical issues faced by the pharmaceutical industry (Mehralian et al. 2016).
Pharmaceutical companies have to obtain and meet certain regulatory rules and
regulations and acquire patent rights for the products innovated and developed by the
company. In the United Kingdom the pharmaceutical industry is being regulated by the
MHRA body. The Regulatory body MHRA is an key executive agency for the
department of health. The MHRA or Medicine and HealthCare products regulatory
Agency is the key regulator in the United Kingdom which approves and guides all the
rules and the regulations in the United Kingdom (Darrow et al. 2015).
Pharmaceutical Industry in UK has shown key interest in there idea for
supporting the various type of Corporate Social Responsibility as the same helps the
company in involvement in various types of activities which are for the wellbeing of the
society in general along with the business of the companies (Das 2016). The CSR
8CORPORATE SOCIAL RESPONSIBILITY
activities followed by the firms like Novartis Pharmacy Services (UK) Ltd, Integrated
Pharmacy Services Ltd, and Novartis Medical are some of the few companies following
there CSR activities regularly and in the best interest of the society. The company’s
serves the society by developing public infrastructures, donating medicine and providing
services in the healthcare industry are some of the common services and features
provided by the company in the field of healthcare. The CSR policies followed by the
companies helps the company and the society on an overall basis provide a better
place to work. It is important for the company to follow policies and action which acts in
the best of interest for all the stakeholders of the company from shareholders to society
which are directly and indirectly related for the overall growth and prosperity of the
company. Reducing Carbon Emissions, Reducing water consumption and providing
better and safe workplace for the employees of the company and a sustainable
environment for the society is some of the key CSR policies followed by the companies
operating in the pharmaceutical industry. The application of CSR policies followed by
the company help the government and the society build public capacities like
infrastructure development, better public policies and deliver quality products and
services to the consumers of the society at large (Aggarwal and Angrish 2017).
Conclusion
From the above discussion, it can be concluded that several ethical issues arise
within the pharmaceutical companies. In order to mitigate these ethical issues, most of
the pharmaceutical companies across the globe are complying with the ethical code of
conduct. Few evidences in UK exemplifies that code of practice owes to secure
acceptance as well as integration of high standards of conduct especially in marketing
medicines. The CSR policies of the companies operating in the pharmaceutical sector
also reflects that they are mainly committed in providing proper and affordable
medication to the community especially to the poor people. In addition to this, the CSR
policies also helps the companies to avoid risk arising due to patient medication. The
requirement of CSR programs in business strategy of pharmaceutical sector helps to
bring about new CSR experts in pharmaceutical sector.
activities followed by the firms like Novartis Pharmacy Services (UK) Ltd, Integrated
Pharmacy Services Ltd, and Novartis Medical are some of the few companies following
there CSR activities regularly and in the best interest of the society. The company’s
serves the society by developing public infrastructures, donating medicine and providing
services in the healthcare industry are some of the common services and features
provided by the company in the field of healthcare. The CSR policies followed by the
companies helps the company and the society on an overall basis provide a better
place to work. It is important for the company to follow policies and action which acts in
the best of interest for all the stakeholders of the company from shareholders to society
which are directly and indirectly related for the overall growth and prosperity of the
company. Reducing Carbon Emissions, Reducing water consumption and providing
better and safe workplace for the employees of the company and a sustainable
environment for the society is some of the key CSR policies followed by the companies
operating in the pharmaceutical industry. The application of CSR policies followed by
the company help the government and the society build public capacities like
infrastructure development, better public policies and deliver quality products and
services to the consumers of the society at large (Aggarwal and Angrish 2017).
Conclusion
From the above discussion, it can be concluded that several ethical issues arise
within the pharmaceutical companies. In order to mitigate these ethical issues, most of
the pharmaceutical companies across the globe are complying with the ethical code of
conduct. Few evidences in UK exemplifies that code of practice owes to secure
acceptance as well as integration of high standards of conduct especially in marketing
medicines. The CSR policies of the companies operating in the pharmaceutical sector
also reflects that they are mainly committed in providing proper and affordable
medication to the community especially to the poor people. In addition to this, the CSR
policies also helps the companies to avoid risk arising due to patient medication. The
requirement of CSR programs in business strategy of pharmaceutical sector helps to
bring about new CSR experts in pharmaceutical sector.
9CORPORATE SOCIAL RESPONSIBILITY
References
Aggarwal, V. and Angrish, A.K., 2017. Corporate Social Responsibility (CSR) and
Pharmaceutical Sector in India: Insights from Annual Reports of Selective Pharma
Companies
Allen, L. and Ansel, H.C., 2013. Ansel's pharmaceutical dosage forms and drug delivery
systems. Lippincott Williams & Wilkins.
Braithwaite, J., 2013. Corporate Crime in the Pharmaceutical Industry (Routledge
Revivals). Routledge.
Cdn.intechopen.com. (2018). [online] Available at:
http://cdn.intechopen.com/pdfs/31746/tech-ethics_in_pharmaceutical_issues.pdf
[Accessed 31 Dec. 2018].
Darrow, J.J., Sarpatwari, A., Avorn, J. and Kesselheim, A.S., 2015. Practical, legal, and
ethical issues in expanded access to investigational drugs.
Das, S.C., 2016. Debates surrounding CSR in pharmaceutical industry with adoption of
ISO 26000. The Business & Management Review, 8(3), p.39.
Filatotchev, I. and Stahl, G.K., 2015. Towards transnational CSR. Corporate social
responsibility approaches and governance solutions for multinational corporations.
Organizational Dynamics, 44(2), pp.121-129.
Gagnon, M.A., 2013. Corruption of pharmaceutical markets: addressing the
misalignment of financial incentives and public health. The Journal of Law, Medicine &
Ethics, 41(3), pp.571-580.
References
Aggarwal, V. and Angrish, A.K., 2017. Corporate Social Responsibility (CSR) and
Pharmaceutical Sector in India: Insights from Annual Reports of Selective Pharma
Companies
Allen, L. and Ansel, H.C., 2013. Ansel's pharmaceutical dosage forms and drug delivery
systems. Lippincott Williams & Wilkins.
Braithwaite, J., 2013. Corporate Crime in the Pharmaceutical Industry (Routledge
Revivals). Routledge.
Cdn.intechopen.com. (2018). [online] Available at:
http://cdn.intechopen.com/pdfs/31746/tech-ethics_in_pharmaceutical_issues.pdf
[Accessed 31 Dec. 2018].
Darrow, J.J., Sarpatwari, A., Avorn, J. and Kesselheim, A.S., 2015. Practical, legal, and
ethical issues in expanded access to investigational drugs.
Das, S.C., 2016. Debates surrounding CSR in pharmaceutical industry with adoption of
ISO 26000. The Business & Management Review, 8(3), p.39.
Filatotchev, I. and Stahl, G.K., 2015. Towards transnational CSR. Corporate social
responsibility approaches and governance solutions for multinational corporations.
Organizational Dynamics, 44(2), pp.121-129.
Gagnon, M.A., 2013. Corruption of pharmaceutical markets: addressing the
misalignment of financial incentives and public health. The Journal of Law, Medicine &
Ethics, 41(3), pp.571-580.
Secure Best Marks with AI Grader
Need help grading? Try our AI Grader for instant feedback on your assignments.
10CORPORATE SOCIAL RESPONSIBILITY
Light, D.W., Lexchin, J. and Darrow, J.J., 2013. Institutional corruption of
pharmaceuticals and the myth of safe and effective drugs.
Mehralian, G., Nazari, J.A., Zarei, L. and Rasekh, H.R., 2016. The effects of corporate
social responsibility on organizational performance in the Iranian pharmaceutical
industry: The mediating role of TQM. Journal of cleaner production, 135, pp.689-698.
Publications.parliament.uk. (2018). [online] Available at:
https://publications.parliament.uk/pa/cm200405/cmselect/cmhealth/42/42.pdf [Accessed
31 Dec. 2018].
Salari, P., Namazi, H., Abdollahi, M., Khansari, F., Nikfar, S., Larijani, B. and Araminia,
B., 2013. Code of ethics for the national pharmaceutical system: Codifying and
compilation. Journal of research in medical sciences: the official journal of Isfahan
University of Medical Sciences, 18(5), p.442.
Salton, R. and Jones, S., 2015. The corporate social responsibility reports of global
pharmaceutical firms. British Journal of Healthcare Management, 21(1), pp.21-25.
Salton, R. and Jones, S., 2015. The corporate social responsibility reports of global
pharmaceutical firms. British Journal of Healthcare Management, 21(1), pp.21-25.
Schenker, Y., Arnold, R.M. and London, A.J., 2014. The ethics of advertising for health
care services. The American journal of bioethics, 14(3), pp.34-43.
Schleper, M.C. and Busse, C., 2013. Toward a standardized supplier code of ethics:
development of a design concept based on diffusion of innovation theory. Logistics
Research, 6(4), pp.187-216.
Turcsanyi, J. and Sisaye, S., 2013. Corporate social responsibility and its link to
financial performance: Application to Johnson & Johnson, a pharmaceutical company.
World Journal of Science, Technology and Sustainable Development, 10(1), pp.4-18.
Youtie, J. and Bozeman, B., 2014. Social dynamics of research collaboration: Norms,
practices, and ethical issues in determining co-authorship rights. Scientometrics, 101(2),
pp.953-962.
Light, D.W., Lexchin, J. and Darrow, J.J., 2013. Institutional corruption of
pharmaceuticals and the myth of safe and effective drugs.
Mehralian, G., Nazari, J.A., Zarei, L. and Rasekh, H.R., 2016. The effects of corporate
social responsibility on organizational performance in the Iranian pharmaceutical
industry: The mediating role of TQM. Journal of cleaner production, 135, pp.689-698.
Publications.parliament.uk. (2018). [online] Available at:
https://publications.parliament.uk/pa/cm200405/cmselect/cmhealth/42/42.pdf [Accessed
31 Dec. 2018].
Salari, P., Namazi, H., Abdollahi, M., Khansari, F., Nikfar, S., Larijani, B. and Araminia,
B., 2013. Code of ethics for the national pharmaceutical system: Codifying and
compilation. Journal of research in medical sciences: the official journal of Isfahan
University of Medical Sciences, 18(5), p.442.
Salton, R. and Jones, S., 2015. The corporate social responsibility reports of global
pharmaceutical firms. British Journal of Healthcare Management, 21(1), pp.21-25.
Salton, R. and Jones, S., 2015. The corporate social responsibility reports of global
pharmaceutical firms. British Journal of Healthcare Management, 21(1), pp.21-25.
Schenker, Y., Arnold, R.M. and London, A.J., 2014. The ethics of advertising for health
care services. The American journal of bioethics, 14(3), pp.34-43.
Schleper, M.C. and Busse, C., 2013. Toward a standardized supplier code of ethics:
development of a design concept based on diffusion of innovation theory. Logistics
Research, 6(4), pp.187-216.
Turcsanyi, J. and Sisaye, S., 2013. Corporate social responsibility and its link to
financial performance: Application to Johnson & Johnson, a pharmaceutical company.
World Journal of Science, Technology and Sustainable Development, 10(1), pp.4-18.
Youtie, J. and Bozeman, B., 2014. Social dynamics of research collaboration: Norms,
practices, and ethical issues in determining co-authorship rights. Scientometrics, 101(2),
pp.953-962.
1 out of 11
Your All-in-One AI-Powered Toolkit for Academic Success.
+13062052269
info@desklib.com
Available 24*7 on WhatsApp / Email
Unlock your academic potential
© 2024 | Zucol Services PVT LTD | All rights reserved.